BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 31602000)

  • 1. BMP signaling mediates glioma stem cell quiescence and confers treatment resistance in glioblastoma.
    Sachdeva R; Wu M; Johnson K; Kim H; Celebre A; Shahzad U; Graham MS; Kessler JA; Chuang JH; Karamchandani J; Bredel M; Verhaak R; Das S
    Sci Rep; 2019 Oct; 9(1):14569. PubMed ID: 31602000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Snail regulates BMP and TGFβ pathways to control the differentiation status of glioma-initiating cells.
    Caja L; Tzavlaki K; Dadras MS; Tan EJ; Hatem G; Maturi NP; Morén A; Wik L; Watanabe Y; Savary K; Kamali-Moghaddan M; Uhrbom L; Heldin CH; Moustakas A
    Oncogene; 2018 May; 37(19):2515-2531. PubMed ID: 29449696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell quiescence correlates with enhanced glioblastoma cell invasion and cytotoxic resistance.
    Atkins RJ; Stylli SS; Kurganovs N; Mangiola S; Nowell CJ; Ware TM; Corcoran NM; Brown DV; Kaye AH; Morokoff A; Luwor RB; Hovens CM; Mantamadiotis T
    Exp Cell Res; 2019 Jan; 374(2):353-364. PubMed ID: 30562483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucocorticoids promote a glioma stem cell-like phenotype and resistance to chemotherapy in human glioblastoma primary cells: Biological and prognostic significance.
    Kostopoulou ON; Mohammad AA; Bartek J; Winter J; Jung M; Stragliotto G; Söderberg-Nauclér C; Landázuri N
    Int J Cancer; 2018 Mar; 142(6):1266-1276. PubMed ID: 29067692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular targeting of TRF2 suppresses the growth and tumorigenesis of glioblastoma stem cells.
    Bai Y; Lathia JD; Zhang P; Flavahan W; Rich JN; Mattson MP
    Glia; 2014 Oct; 62(10):1687-98. PubMed ID: 24909307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Divergent evolution of temozolomide resistance in glioblastoma stem cells is reflected in extracellular vesicles and coupled with radiosensitization.
    Garnier D; Meehan B; Kislinger T; Daniel P; Sinha A; Abdulkarim B; Nakano I; Rak J
    Neuro Oncol; 2018 Jan; 20(2):236-248. PubMed ID: 29016925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metformin and temozolomide act synergistically to inhibit growth of glioma cells and glioma stem cells in vitro and in vivo.
    Yu Z; Zhao G; Xie G; Zhao L; Chen Y; Yu H; Zhang Z; Li C; Li Y
    Oncotarget; 2015 Oct; 6(32):32930-43. PubMed ID: 26431379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Core pathway mutations induce de-differentiation of murine astrocytes into glioblastoma stem cells that are sensitive to radiation but resistant to temozolomide.
    Schmid RS; Simon JM; Vitucci M; McNeill RS; Bash RE; Werneke AM; Huey L; White KK; Ewend MG; Wu J; Miller CR
    Neuro Oncol; 2016 Jul; 18(7):962-73. PubMed ID: 26826202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The lncRNA TP73-AS1 is linked to aggressiveness in glioblastoma and promotes temozolomide resistance in glioblastoma cancer stem cells.
    Mazor G; Levin L; Picard D; Ahmadov U; Carén H; Borkhardt A; Reifenberger G; Leprivier G; Remke M; Rotblat B
    Cell Death Dis; 2019 Mar; 10(3):246. PubMed ID: 30867410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular characteristics of single patient-derived glioma stem-like cells from primary and recurrent glioblastoma.
    Shi J; Dong X; Han W; Zhou P; Liu L; Wang H; Jiang Q; Li H; Cheng S; Li S; Yuan J; Qian Z; Dong J
    Anticancer Drugs; 2022 Jan; 33(1):e381-e388. PubMed ID: 34419956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tetraspanin CD9 stabilizes gp130 by preventing its ubiquitin-dependent lysosomal degradation to promote STAT3 activation in glioma stem cells.
    Shi Y; Zhou W; Cheng L; Chen C; Huang Z; Fang X; Wu Q; He Z; Xu S; Lathia JD; Ping Y; Rich JN; Bian XW; Bao S
    Cell Death Differ; 2017 Jan; 24(1):167-180. PubMed ID: 27740621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glioblastoma and stem cells.
    Altaner C
    Neoplasma; 2008; 55(5):369-74. PubMed ID: 18665745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic Suppression of Glioblastoma Cell Growth by Combined Application of Temozolomide and Dopamine D2 Receptor Antagonists.
    Liu Z; Jiang X; Gao L; Liu X; Li J; Huang X; Zeng T
    World Neurosurg; 2019 Aug; 128():e468-e477. PubMed ID: 31048057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer stem cell-vascular endothelial cell interactions in glioblastoma.
    Sharma A; Shiras A
    Biochem Biophys Res Commun; 2016 May; 473(3):688-92. PubMed ID: 26692486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. mTOR inhibition decreases SOX2-SOX9 mediated glioma stem cell activity and temozolomide resistance.
    Garros-Regulez L; Aldaz P; Arrizabalaga O; Moncho-Amor V; Carrasco-Garcia E; Manterola L; Moreno-Cugnon L; Barrena C; Villanua J; Ruiz I; Pollard S; Lovell-Badge R; Sampron N; Garcia I; Matheu A
    Expert Opin Ther Targets; 2016; 20(4):393-405. PubMed ID: 26878385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo RNAi screen for BMI1 targets identifies TGF-β/BMP-ER stress pathways as key regulators of neural- and malignant glioma-stem cell homeostasis.
    Gargiulo G; Cesaroni M; Serresi M; de Vries N; Hulsman D; Bruggeman SW; Lancini C; van Lohuizen M
    Cancer Cell; 2013 May; 23(5):660-76. PubMed ID: 23680149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Connective tissue growth factor promotes temozolomide resistance in glioblastoma through TGF-β1-dependent activation of Smad/ERK signaling.
    Zeng H; Yang Z; Xu N; Liu B; Fu Z; Lian C; Guo H
    Cell Death Dis; 2017 Jun; 8(6):e2885. PubMed ID: 28617438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quiescent human glioblastoma cancer stem cells drive tumor initiation, expansion, and recurrence following chemotherapy.
    Xie XP; Laks DR; Sun D; Ganbold M; Wang Z; Pedraza AM; Bale T; Tabar V; Brennan C; Zhou X; Parada LF
    Dev Cell; 2022 Jan; 57(1):32-46.e8. PubMed ID: 35016005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic targeting of malignant glioma.
    Alexandru-Abrams D; Jadus MR; Hsu FP; Stathopoulos A; Bota DA
    Anticancer Agents Med Chem; 2014; 14(8):1075-84. PubMed ID: 25175690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Negative control of the HGF/c-MET pathway by TGF-β: a new look at the regulation of stemness in glioblastoma.
    Papa E; Weller M; Weiss T; Ventura E; Burghardt I; Szabó E
    Cell Death Dis; 2017 Dec; 8(12):3210. PubMed ID: 29238047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.